Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting TLR4 with ApTOLL Improves Heart Function in Response to Coronary Ischemia Reperfusion in Pigs Undergoing Acute Myocardial Infarction
Rafael Ramírez-Carracedo, Laura Tesoro, Ignacio Hernández, et al.
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1167-1167
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Signaling pathways and targeted therapy for myocardial infarction
Qing Zhang, Lu Wang, Shiqi Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 468
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers
Macarena Hernández‐Jiménez, Samuel Martín‐Vílchez, Dolores Ochoa, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 124-135
Open Access | Times Cited: 41
Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment
Macarena Hernández‐Jiménez, Francisco Abad‐Santos, Ian A. Cotgreave, et al.
JAMA Neurology (2023) Vol. 80, Iss. 8, pp. 779-779
Closed Access | Times Cited: 36
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke
Macarena Hernández‐Jiménez, Francisco Abad‐Santos, Ian A. Cotgreave, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 28
Hirsutine ameliorates myocardial ischemia-reperfusion injury through improving mitochondrial function via CaMKII pathway
Wen Jiang, Yuxiang Zhang, Wei Zhang, et al.
Clinical and Experimental Hypertension (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 26
Current status and future perspectives of platelet-derived extracellular vesicles in cancer diagnosis and treatment
Tongtao Zhuang, Shenrong Wang, Xiaoqian Yu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
ApTOLL: A new therapeutic aptamer for cytoprotection and (re)myelination after multiple sclerosis
Beatriz Fernández‐Gómez, Miguel Marchena, David Piñeiro, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 17, pp. 3263-3281
Open Access | Times Cited: 7
Cerebroprotective Effects of the TLR4-Binding DNA Aptamer ApTOLL in a Rat Model of Ischemic Stroke and Thrombectomy Recanalization
Alicia Aliena‐Valero, Macarena Hernández‐Jiménez, Mikahela A. López‐Morales, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 741-741
Open Access | Times Cited: 4
The effects of the combination therapy of chemotherapy drugs on the fluctuations of genes involved in the TLR signaling pathway in glioblastoma multiforme therapy
Seyedeh Elham Norollahi, Shahrokh Yousefzadeh-Chabok, Bahman Yousefi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117137-117137
Closed Access | Times Cited: 4
ApTOLL ameliorates cognitive dysfunction and brain injury in ischemic stroke by regulating the miR-335-5p/IRAK1 axis
Feng Qin, Xiang Feng, H. J. Yang, et al.
Neurotherapeutics (2025), pp. e00573-e00573
Open Access
Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction
Marta Paz-García, Adrián Povo‐Retana, Rafael I. Jaén, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114214-114214
Open Access | Times Cited: 10
Expression characteristics of lipid metabolism-related genes and correlative immune infiltration landscape in acute myocardial infarction
Jiahe Wu, Jingyi Luo, Huanhuan Cai, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
MiR-182-5p Mediated by Exosomes Derived From Bone Marrow Mesenchymal Stem Cell Attenuates Inflammatory Responses by Targeting TLR4 in a Mouse Model of Myocardial Infraction
Chuang Sun, Wei Li, Yanhong Li, et al.
Immune Network (2022) Vol. 22, Iss. 6
Open Access | Times Cited: 14
Maresin1 ameliorates ventricular remodelling and arrhythmia in mice models of myocardial infarction via NRF2/HO-1 and TLR4/NF-kB signalling
Fengyuan Wang, Gong Yang, Tao Chen, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109369-109369
Closed Access | Times Cited: 12
Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors
Sumra Komal, Nimrah Komal, Ali Mujtaba, et al.
Immunologic Research (2022) Vol. 70, Iss. 5, pp. 607-623
Closed Access | Times Cited: 11
A review on regulation of DNA methylation during post-myocardial infarction
Wenqiang Han, Wenxin Wang, Qinhong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Upregulation of SPI1 during myocardial infarction aggravates cardiac tissue injury and disease progression through activation of the TLR4/NFκB axis.
Zhengling Liu, Shuai Huang
PubMed (2022) Vol. 14, Iss. 4, pp. 2709-2727
Closed Access | Times Cited: 10
Upregulation of SLAMF8 aggravates ischemia/reperfusion-induced ferroptosis and injury in cardiomyocyte
Yuli Zheng, Liudi Wang, Yan Zhao, et al.
International Journal of Cardiology (2023) Vol. 399, pp. 131688-131688
Closed Access | Times Cited: 5
Identification of molecular signatures in acute myocardial infarction based on integrative analysis of proteomics and transcriptomics
Jiawen Wu, Jiale Yan, Zheng Hua, et al.
Genomics (2023) Vol. 115, Iss. 5, pp. 110701-110701
Open Access | Times Cited: 4
NIL10: A New IL10-Receptor Binding Nanoparticle That Induces Cardiac Protection in Mice and Pigs Subjected to Acute Myocardial Infarction through STAT3/NF-κB Activation
Laura Tesoro, Ignacio Hernández, Rafael Ramírez-Carracedo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2044-2044
Open Access | Times Cited: 7
Ivabradine-Stimulated Microvesicle Release Induces Cardiac Protection against Acute Myocardial Infarction
Rafael Ramírez-Carracedo, Laura Tesoro, Ignacio Hernández, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6566-6566
Open Access | Times Cited: 9
Inhaled aptamer therapy: A hopeful therapy for lung disease
M. Elena Martı́n
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 875-876
Open Access | Times Cited: 3
Current Status and Challenges of Aptamers Screening and Optimization
Yong Tan, Lan Ma, Xue Yang, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 26, Iss. 6, pp. 1067-1082
Closed Access | Times Cited: 5
First in Human Clinical Trial to compare Safety and Tolerability between Intravenous Infusion and Bolus Intravenous Injection of ApTOLL in Healthy Volunteers
Macarena Hernández‐Jiménez, Samuel Martín‐Vílchez, Gina Mejía‐Abril, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 36, Iss. 1, pp. 102435-102435
Open Access
ApTOLL, a new therapeutic aptamer for cytoprotection and (re)myelination after Multiple Sclerosis
Beatriz Fernández‐Gómez, Miguel Marchena, David Piñeiro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top